++
Chapter 4. Medication Therapy Management Quality and Performance Improvement
++
++
++
The Institute of Medicine strategies for healthcare improvement include:
++
++
++
a. paying for injuries resulting from unsafe care.
++
++
b. applying the Medicare star ratings to community pharmacy practice.
++
++
c. prescribing the role of each profession.
++
++
d. requiring the use of telehealth technology.
++
++
++
++
++
CMS MTM-related star ratings:
++
++
++
a. are based on pharmacy ADR detection and resolution.
++
++
b. are primarily focused on Part D MTM.
++
++
c. are used to inform the public about diagnostic error rates.
++
++
d. may change from year to year.
++
++
e. are used for healthcare organization accreditation purposes.
++
++
++
Star rating underperformance by an MA-PD can result in:
++
++
++
a. civil monetary fines for underperformance.
++
++
b. members being automatically disenrolled from the plan.
++
++
c. loss of quality bonus payment.
++
++
d. the MA-PD plan being required to switch to a PDP.
++
++
++
++
++
The CMS MA-PD PDP star performance measures system is best characterized as:
++
++
++
a. a rate-based measure system.
++
++
b. proven to improved patient outcomes.
++
++
c. including diagnostic accuracy measures.
++
++
d. including physician acceptance rates of suggested therapeutic changes.
++
++
e. primarily focused on formulary design.
++
++
++
Improving the MA-PD medication star measures for an individual plan from 4 to 5 guarantees:
++
++
++
a. overall star ratings will be 4.
++
++
b. overall star ratings will be 4.5.
++
++
c. overall star ratings will be 5.0.
++
++
d. a quality bonus of 5%.
++
++
e. nothing, as the rating depends on other performance measures.
++
++
++
Which of the following are included in the CMS quality improvement framework?
++
++
++
++
++
++...